Report Detail

Other Global Immune Repertoire Sequencing Market Size, Status and Forecast 2019-2025

  • RnM3472563
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Other

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Immune Repertoire Sequencing Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Pyro-Sequencing
      • 1.4.3 Dye-Terminating Sequencing
      • 1.4.4 Semiconductor Sequencing
      • 1.4.5 Others
    • 1.5 Market by Application
      • 1.5.1 Global Immune Repertoire Sequencing Market Share by Application (2014-2025)
      • 1.5.2 Biomarker Discovery
      • 1.5.3 Infectious Diseases
      • 1.5.4 Vaccine Development and Efficacy
      • 1.5.5 Cancer Immunotherapy
      • 1.5.6 Autoimmune Disease
      • 1.5.7 Transplant Rejection and Tolerance
      • 1.5.8 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Immune Repertoire Sequencing Market Size
    • 2.2 Immune Repertoire Sequencing Growth Trends by Regions
      • 2.2.1 Immune Repertoire Sequencing Market Size by Regions (2014-2025)
      • 2.2.2 Immune Repertoire Sequencing Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Immune Repertoire Sequencing Market Size by Manufacturers
      • 3.1.1 Global Immune Repertoire Sequencing Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Immune Repertoire Sequencing Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Immune Repertoire Sequencing Market Concentration Ratio (CR5 and HHI)
    • 3.2 Immune Repertoire Sequencing Key Players Head office and Area Served
    • 3.3 Key Players Immune Repertoire Sequencing Product/Solution/Service
    • 3.4 Date of Enter into Immune Repertoire Sequencing Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Immune Repertoire Sequencing Market Size by Type (2014-2019)
    • 4.2 Global Immune Repertoire Sequencing Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Immune Repertoire Sequencing Market Size (2014-2019)
    • 5.2 Immune Repertoire Sequencing Key Players in United States
    • 5.3 United States Immune Repertoire Sequencing Market Size by Type
    • 5.4 United States Immune Repertoire Sequencing Market Size by Application

    6 Europe

    • 6.1 Europe Immune Repertoire Sequencing Market Size (2014-2019)
    • 6.2 Immune Repertoire Sequencing Key Players in Europe
    • 6.3 Europe Immune Repertoire Sequencing Market Size by Type
    • 6.4 Europe Immune Repertoire Sequencing Market Size by Application

    7 China

    • 7.1 China Immune Repertoire Sequencing Market Size (2014-2019)
    • 7.2 Immune Repertoire Sequencing Key Players in China
    • 7.3 China Immune Repertoire Sequencing Market Size by Type
    • 7.4 China Immune Repertoire Sequencing Market Size by Application

    8 Japan

    • 8.1 Japan Immune Repertoire Sequencing Market Size (2014-2019)
    • 8.2 Immune Repertoire Sequencing Key Players in Japan
    • 8.3 Japan Immune Repertoire Sequencing Market Size by Type
    • 8.4 Japan Immune Repertoire Sequencing Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Immune Repertoire Sequencing Market Size (2014-2019)
    • 9.2 Immune Repertoire Sequencing Key Players in Southeast Asia
    • 9.3 Southeast Asia Immune Repertoire Sequencing Market Size by Type
    • 9.4 Southeast Asia Immune Repertoire Sequencing Market Size by Application

    10 India

    • 10.1 India Immune Repertoire Sequencing Market Size (2014-2019)
    • 10.2 Immune Repertoire Sequencing Key Players in India
    • 10.3 India Immune Repertoire Sequencing Market Size by Type
    • 10.4 India Immune Repertoire Sequencing Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Immune Repertoire Sequencing Market Size (2014-2019)
    • 11.2 Immune Repertoire Sequencing Key Players in Central & South America
    • 11.3 Central & South America Immune Repertoire Sequencing Market Size by Type
    • 11.4 Central & South America Immune Repertoire Sequencing Market Size by Application

    12 International Players Profiles

    • 12.1 ArcherDX
      • 12.1.1 ArcherDX Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Immune Repertoire Sequencing Introduction
      • 12.1.4 ArcherDX Revenue in Immune Repertoire Sequencing Business (2014-2019)
      • 12.1.5 ArcherDX Recent Development
    • 12.2 Junom Therapeutics
      • 12.2.1 Junom Therapeutics Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Immune Repertoire Sequencing Introduction
      • 12.2.4 Junom Therapeutics Revenue in Immune Repertoire Sequencing Business (2014-2019)
      • 12.2.5 Junom Therapeutics Recent Development
    • 12.3 Roche Holding
      • 12.3.1 Roche Holding Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Immune Repertoire Sequencing Introduction
      • 12.3.4 Roche Holding Revenue in Immune Repertoire Sequencing Business (2014-2019)
      • 12.3.5 Roche Holding Recent Development
    • 12.4 Illumina
      • 12.4.1 Illumina Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Immune Repertoire Sequencing Introduction
      • 12.4.4 Illumina Revenue in Immune Repertoire Sequencing Business (2014-2019)
      • 12.4.5 Illumina Recent Development
    • 12.5 ThermoFisher Scietific
      • 12.5.1 ThermoFisher Scietific Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Immune Repertoire Sequencing Introduction
      • 12.5.4 ThermoFisher Scietific Revenue in Immune Repertoire Sequencing Business (2014-2019)
      • 12.5.5 ThermoFisher Scietific Recent Development
    • 12.6 Pacific Biosciences
      • 12.6.1 Pacific Biosciences Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Immune Repertoire Sequencing Introduction
      • 12.6.4 Pacific Biosciences Revenue in Immune Repertoire Sequencing Business (2014-2019)
      • 12.6.5 Pacific Biosciences Recent Development
    • 12.7 CD Genomics
      • 12.7.1 CD Genomics Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Immune Repertoire Sequencing Introduction
      • 12.7.4 CD Genomics Revenue in Immune Repertoire Sequencing Business (2014-2019)
      • 12.7.5 CD Genomics Recent Development
    • 12.8 Atreca
      • 12.8.1 Atreca Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Immune Repertoire Sequencing Introduction
      • 12.8.4 Atreca Revenue in Immune Repertoire Sequencing Business (2014-2019)
      • 12.8.5 Atreca Recent Development
    • 12.9 Adaptive Biotechnologies
      • 12.9.1 Adaptive Biotechnologies Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Immune Repertoire Sequencing Introduction
      • 12.9.4 Adaptive Biotechnologies Revenue in Immune Repertoire Sequencing Business (2014-2019)
      • 12.9.5 Adaptive Biotechnologies Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Immune Repertoire is the collection of B and T cells with functional diversity in the body that reflects the immune selectivity. Immune Repertoire Sequencing means to sequence the complimentary determining region of both B-cell receptor and T-cell receptor. Immune receptor repertoire profiling portrays as the antigen-specific information within lymphocytes and has become increasingly significant to understand body’s autoimmunity and healthy immunity. This also propose novel ways to tackle cancer and development of personalized medicine by understanding the genetic makeup of a person. Since the last two decades, the technical advancements in the high throughput sequencing techniques along with the development in the bioinformatics and statistical tools have made the immune repertoire sequencing to be analyzed at single sequence level. This technology has potential to explore for the novel infectious agents and also offers new approaches for vaccine or antibody development.
      In 2018, the global Immune Repertoire Sequencing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Immune Repertoire Sequencing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immune Repertoire Sequencing development in United States, Europe and China.

      The key players covered in this study
      ArcherDX
      Junom Therapeutics
      Roche Holding
      Illumina
      ThermoFisher Scietific
      Pacific Biosciences
      CD Genomics
      Atreca
      Adaptive Biotechnologies

      Market segment by Type, the product can be split into
      Pyro-Sequencing
      Dye-Terminating Sequencing
      Semiconductor Sequencing
      Others

      Market segment by Application, split into
      Biomarker Discovery
      Infectious Diseases
      Vaccine Development and Efficacy
      Cancer Immunotherapy
      Autoimmune Disease
      Transplant Rejection and Tolerance
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Immune Repertoire Sequencing status, future forecast, growth opportunity, key market and key players.
      To present the Immune Repertoire Sequencing development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Immune Repertoire Sequencing are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Immune Repertoire Sequencing. Industry analysis & Market Report on Immune Repertoire Sequencing is a syndicated market report, published as Global Immune Repertoire Sequencing Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Immune Repertoire Sequencing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,092.70
      4,639.05
      6,185.40
      3,534.29
      5,301.43
      7,068.58
      422,705.40
      634,058.10
      845,410.80
      277,136.34
      415,704.51
      554,272.68
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report